STOCK TITAN
  1. Home
  2. Sec-filings
  3. CL
  4. [Form 4] COLGATE PALMOLIVE CO Insider Trading Activity

Director at Colgate-Palmolive (NYSE: CL) receives stock and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Colgate-Palmolive director Christopher S. Boerner reported equity compensation awards. He received an annual director stock grant of 1,383 shares of common stock under the company’s incentive compensation plan, leaving him with 1,383 common shares directly owned after the award.

He was also granted a stock option for 2,020 shares of common stock with an exercise price of $86.74 per share, expiring on May 11, 2034. The option becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the May 11, 2026 grant date. These are compensation-related awards rather than open-market purchases or sales.

Positive

  • None.

Negative

  • None.
Insider BOERNER CHRISTOPHER S.
Role null
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 2,020 $0.00 --
Grant/Award Common Stock 1,383 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 2,020 shares (Direct, null); Common Stock — 1,383 shares (Direct, null)
Footnotes (1)
  1. Annual director stock grant under the issuer's incentive compensation plan. Annual director stock option grant under the issuer's incentive compensation plan. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Director stock grant 1,383 shares Annual director stock grant of common stock
Common shares held 1,383 shares Total common stock directly owned after grant
Stock option grant size 2,020 shares Annual director stock option covering common stock
Option exercise price $86.74 per share Stock option (right to buy) strike price
Option expiration May 11, 2034 Stock option expiration date
Vesting period 3 years Equal annual installments starting first anniversary of May 11, 2026 grant date
incentive compensation plan financial
"Annual director stock grant under the issuer's incentive compensation plan."
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan."
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BOERNER CHRISTOPHER S.
(Last)(First)(Middle)
C/O COLGATE-PALMOLIVE COMPANY
300 PARK AVENUE
(Street)
NEW YORK NEW YORK 10022
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/11/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/11/2026A(1)1,383A$0.00001,383D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$86.7405/11/2026A(2)2,020 (3)05/11/2034Common Stock2,020$0.00002,020D
Explanation of Responses:
1. Annual director stock grant under the issuer's incentive compensation plan.
2. Annual director stock option grant under the issuer's incentive compensation plan.
3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
/s/ Kristine Hutchinson, Attorney-in-Fact05/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Colgate-Palmolive (CL) director Christopher S. Boerner report in this Form 4?

Christopher S. Boerner reported receiving equity compensation awards, not open-market trades. He was granted 1,383 shares of common stock and a stock option for 2,020 shares under Colgate-Palmolive’s incentive compensation plan as part of his annual director compensation.

How many Colgate-Palmolive shares did Christopher S. Boerner receive in the latest grant?

He received 1,383 shares of Colgate-Palmolive common stock as an annual director stock grant. Following this award, his reported direct common stock holdings total 1,383 shares, reflecting the compensation-related nature of this transaction rather than a market purchase.

What are the key terms of Christopher S. Boerner’s new Colgate-Palmolive stock option?

He was granted a stock option covering 2,020 shares of Colgate-Palmolive common stock at an exercise price of $86.74 per share. The option expires on May 11, 2034 and vests in equal annual installments over three years starting one year after the grant date.

Is Christopher S. Boerner’s Form 4 for Colgate-Palmolive a stock purchase or compensation award?

The filing reflects compensation awards, not an open-market stock purchase. It records an annual director stock grant of 1,383 shares and an annual stock option grant for 2,020 shares, both made under Colgate-Palmolive’s incentive compensation plan.

How does the vesting schedule work for Christopher S. Boerner’s Colgate-Palmolive stock option grant?

The option becomes exercisable in three equal annual installments. Vesting begins on the first anniversary of the May 11, 2026 grant date, so one-third vests each year over three years, aligning with typical multi-year director compensation structures.